Putting metabolic side effects into perspective: Risks versus benefits of atypical antipsychotics

Herbert Y. Meltzer*

*Corresponding author for this work

Research output: Contribution to journalReview article

44 Scopus citations

Abstract

The lengthy list of the side effects and morbidity associated with the atypical antipsychotics might make a patient with psychosis and his or her caregivers so concerned about the use of any of these medications, particularly those associated with a higher risk of diabetes, weight gain, or increased lipid levels, that they would prefer to avoid all of them. However, schizophrenia is associated with a relatively high risk for several diseases, including diabetes, that is independent of the risks that are linked to atypical antipsychotic use. Therefore, the clinician who might think, "Why use atypicals if using the typical drugs will escape the problems of monitoring and all the associated effects of diabetes and hyperglycemia?" needs to know that these problems cannot be avoided simply by choosing typical antipsychotics. Clinicians, patients, and concerned family members must balance the significant benefits of atypical antipsychotic treatment - improved cognition, reduced suicidality, and less depression - against the risks of metabolic disturbances and select a course of treatment that includes a realistic monitoring program.

Original languageEnglish (US)
Pages (from-to)35-39
Number of pages5
JournalJournal of Clinical Psychiatry
Volume62
Issue numberSUPPL. 27
StatePublished - Dec 1 2001

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Putting metabolic side effects into perspective: Risks versus benefits of atypical antipsychotics'. Together they form a unique fingerprint.

  • Cite this